Amundi Index Solutions - Amundi Index MSCI Europe IE-DRegister to Unlock Ratings |
Performance History | 31/05/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 2.2 | 17.6 | -4.1 | 13.3 | 8.4 | |
+/-Cat | -2.1 | 2.3 | 4.2 | 1.8 | 1.0 | |
+/-B’mrk | -0.3 | 0.0 | 0.4 | 0.2 | -0.1 | |
Category: Europe Large-Cap Blend Equity | ||||||
Category Benchmark: Morningstar DM Eur TME NR EUR |
Key Stats | ||
NAV 11/06/2024 | EUR 1961.12 | |
Day Change | -0.96% | |
Morningstar Category™ | Europe Large-Cap Blend Equity | |
ISIN | LU0389811612 | |
Fund Size (Mil) 11/06/2024 | EUR 4221.05 | |
Share Class Size (Mil) 11/06/2024 | EUR 5.75 | |
Max Initial Charge | 2.50% | |
Ongoing Charge 11/02/2022 | 0.15% |
Investment Objective: Amundi Index Solutions - Amundi Index MSCI Europe IE-D |
To track the performance of MSCI Europe Index (the "Index"), and to minimize the tracking error between the net asset value of the sub-fund and the performance of the Index. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Isabelle Lafargue 07/09/2015 | ||
Inception Date 25/09/2008 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe NR EUR | Morningstar DM Eur TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Amundi Index Solutions - Amundi Index MSCI Europe IE-D | 07/06/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 4.16 |
ASML Holding NV | Technology | 3.70 |
Nestle SA | Consumer Defensive | 2.61 |
AstraZeneca PLC | Healthcare | 2.22 |
Lvmh Moet Hennessy Louis Vuitton SE | Consumer Cyclical | 2.03 |
Increase Decrease New since last portfolio | ||
Amundi Index Solutions - Amundi Index MSCI Europe IE-D |